Back
Heron Therapeutics Stock Price Chart
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
HRTX
Heron Therapeutics
Last Price:
2.01
Seasonality Move:
-7.28%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and HRTX is experiencing slight selling pressure.
Heron Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.88 | Buy |
| 20-day SMA: | 1.87 | Buy |
| 50-day SMA: | 2.36 | Sell |
| 200-day SMA: | 2.59 | Sell |
| 8-day EMA: | 1.9 | Buy |
| 20-day EMA: | 1.94 | Buy |
| 50-day EMA: | 2.24 | Sell |
| 200-day EMA: | 2.47 | Sell |
Heron Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 50.06 | Buy |
| Chaikin Money Flow: | -789183 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.82 - 1.96) | Buy |
| Bollinger Bands (100): | (2.12 - 3.44) | Sell |
Heron Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Heron Therapeutics Stock
Is Heron Therapeutics Stock a Buy?
- Heron Therapeutics share price is 2.01 while HRTX 8-day simple moving average is 1.88, which is a Buy signal.
- The stock price of HRTX is 2.01 while Heron Therapeutics 20-day SMA is 1.87, which makes it a Buy.
- Heron Therapeutics 50-day simple moving average is 2.36 while HRTX share price is 2.01, making it a Sell technically.
- HRTX stock price is 2.01 and Heron Therapeutics 200-day simple moving average is 2.59, creating a Sell signal.
HRTX Technical Analysis vs Fundamental Analysis
Sell
20
Heron Therapeutics (HRTX)
is a Sell
Is Heron Therapeutics a Buy or a Sell?
-
Heron Therapeutics stock is rated a Sell
The current Heron Therapeutics [HRTX] share price is $2.01. The Score for HRTX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Heron Therapeutics Stock Info
Market Cap:
304.09M
Price in USD:
2.01
Share Volume:
2.53M
Heron Therapeutics 52-Week Range
52-Week High:
3.93
52-Week Low:
0.50
Sell
20
Heron Therapeutics (HRTX)
is a Sell
Heron Therapeutics Share Price Forecast
-
What is the Heron Therapeutics stock price today?
The Heron Therapeutics stock price is 2.01 USD today. -
Will HRTX stock go up or go down?
Heron Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Heron Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Heron Therapeutics is overvalued.
Is Heron Therapeutics Stock a Buy?
- Heron Therapeutics share price is 2.01 while HRTX 8-day exponential moving average is 1.90, which is a Buy signal.
- The stock price of HRTX is 2.01 while Heron Therapeutics 20-day EMA is 1.94, which makes it a Buy.
- Heron Therapeutics 50-day exponential moving average is 2.24 while HRTX share price is 2.01, making it a Sell technically.
- HRTX stock price is 2.01 and Heron Therapeutics 200-day simple moving average is 2.47, creating a Sell signal.
Fundamental Analysis of Heron Therapeutics
Is Heron Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.13 per share.
Technical Analysis of Heron Therapeutics
Should I short Heron Therapeutics stock?
- HRTX Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Heron Therapeutics is a Sell
- Heron Therapeutics Relative Strength Index (RSI) is 50.06, which suggest Heron Therapeutics is overbought
- The Bollinger Bands (25) for Heron Therapeutics is (1.82 - 1.96), which suggest Heron Therapeutics is a Sell
- The Bollinger Bands (100) for Heron Therapeutics is (2.12 - 3.44), which suggest Heron Therapeutics is a Sell
* Heron Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.